FDA clears Medtronic's MR surgical leads

Mar 2, 2016

Device manufacturer Medtronic has received clearance from the U.S. Food and Drug Administration (FDA) for its Specify SureScan MR surgical leads for implanted neurostimulation systems for chronic pain.

The leads complete the company's portfolio of FDA-approved spinal cord stimulation systems for full-body MR, the company said. Physicians can now offer patients a full-body MR-conditional spinal cord stimulation system regardless of the type of neurostimulator or lead.

Specify SureScan MR surgical leads will be available to physicians and patients later this month, according to Medtronic.

        An unexpected error occurred: Network error: Response not successful: Received status code 500

            [
  {
    "message": "Cannot execute GraphQL operations after the server has stopped.",
    "extensions": {
      "code": "INTERNAL_SERVER_ERROR"
    }
  }
]

FDA clears Medtronic's MR surgical leads

Short is just as sweet for breast MRI protocol

DTI-MRI algorithm helps evaluate mild TBI, migraines

Smart Choice MRI promotes low-cost MRI scans

Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite